Here, we integrated and refined TCGA sourced tumor-related DEGs with genes from TISIDB related to immune to ultimately establish a four-gene prognostic signature comprising CD276, MS4A1, IGFBP1 and CD200, which has the ability to reflect ICIs responses and survival outcomes. The gene discussed is CD200; the disease is neoplasm.